Bio-Techne to Present at the BofA Securities 2025 Health Care Conference

Bio-Techne Corporation (NASDAQ: TECH) has announced that its President and CEO, Kim Kelderman, will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 10:40 a.m. PDT.

Rhea-AI Summary

Bio-Techne Corporation (NASDAQ: TECH) has announced that its President and CEO, Kim Kelderman, will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 10:40 a.m. PDT. Investors and interested parties can access a live webcast of the presentation through Bio-Techne's Investor Relations website, specifically on the IR Calendar page.

Argus Session date unavailable

+2.11% session move Open Argus

Details

News Market Reaction – TECH

The recorded move for TECH in the trading session of this news was +2.11%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, May 8, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 10:40 a.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has over 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube.

Contact:	David Clair, Vice President, Investor Relations & Corporate Development
	david.clair@bio-techne.com
	612-656-4416

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-bofa-securities-2025-health-care-conference-302448431.html

SOURCE Bio-Techne Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Bio-Techne (TECH) presenting at the BofA Securities 2025 Health Care Conference?

Bio-Techne will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 10:40 a.m. PDT.

Who will represent Bio-Techne (TECH) at the BofA Securities 2025 Health Care Conference?

Kim Kelderman, President and Chief Executive Officer of Bio-Techne, will present at the conference.

How can investors watch Bio-Techne's (TECH) presentation at the BofA Securities conference?

Investors can watch the live webcast through Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

What is the stock symbol for Bio-Techne Corporation?

Bio-Techne Corporation trades on the NASDAQ under the symbol TECH.